Condition: Degenerative Disc Disease (DDD) · Spinal Stenosis · Spondylolisthesis · Sponsor: Metrosan End. ve Elk. Mek. Cihazlar ve Tibbi Malz. San. Tic. Ltd. Co.
This is a prospective, multi-center, observational Post-Market Clinical Follow-Up (PMCF) study designed to collect additional safety and clinical performance data on CE-marked Titania® spinal instrumentation and fusion systems, and Bonegraft® bone filling materials (synthetic bone grafts and bone cements). The study aims to evaluate short-term (12-month) safety and effectiveness, identify previously unknown side effects, monitor defined complications, and assess risks based on real-world evidence in patients undergoing spinal surgery. All investigated products are used within their intended purpose under routine clinical practice.
This description comes directly from the study's public registry record.
Burak Tülü, Sponsor's Representative · +90 (236) 213 10 14 · b.tulu@metrosan.com.tr
Always discuss trial participation with your own doctor first.
| Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Neurosurgery | Izmir, Turkey (Türkiye) | Recruiting |
| Demokrasi University Buca Seyfi Demirsoy Training and Research Hospital, Department of Neurosurgery | Izmir, Turkey (Türkiye) | Not Yet Recruiting |
| Van Yuzuncu Yil University Dursun Odabas Medical Center, Department of Neurosurgery | Van, Turkey (Türkiye) | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07615491